(Q33181907)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306150%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

A three-outcome design for phase II clinical trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306150%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

main subject

phase II clinical trial

0 references

author

Daniel J. Sargent

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306150%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

V Chan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306150%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

R M Goldberg

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306150%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 April 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306150%20AND%20SRC:MED&resulttype=core&format=json

Contemporary Clinical Trials

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306150%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306150%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

117-125

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306150%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306150%20AND%20SRC:MED&resulttype=core&format=json

One-sample multiple testing procedure for phase II clinical trials

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900115-X

7 January 2021

Optimal two-stage designs for phase II clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900115-X

7 January 2021

A design alternative for two-stage, phase II, multicenter cancer clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900115-X

7 January 2021

A class of phase II designs with three possible outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900115-X

7 January 2021

Bayesian sequential monitoring designs for single-arm clinical trials with multiple outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900115-X

7 January 2021

Incorporating toxicity considerations into the design of two-stage phase II clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900115-X

7 January 2021

Sample size determination for phase II clinical trials based on Bayesian decision theory.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900115-X

7 January 2021

10.1016/S0197-2456(00)00115-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306150%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference